A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination

The rapid development and implementation of COVID-19 vaccines throughout the global population has given rise to unique, rare, adverse skin reactions. This case report describes an elderly man with new-onset bullous pemphigoid following the second dose of the Pfizer-BioNTech (mRNA) COVID-19 vaccine.
Source: Dermatology Online Journal - Category: Dermatology Source Type: research